Literature DB >> 16908443

Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts.

W K Al-Delaimy1, E H J M Jansen, P H M Peeters, J D van der Laan, P A H van Noord, H C Boshuizen, Y T van der Schouw, M Jenab, P Ferrari, H B Bueno-de-Mesquita.   

Abstract

Biomarkers are widely used in epidemiology, yet there are few reliability studies to assess the appropriateness of using these biomarkers for the assessment of exposure-disease relationships. The aim of the study was to assess the reliability of 20 biomarkers in serum collected from two Dutch centres (Utrecht and Bilthoven) participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) at two points several years apart. Blood samples were collected from 30 men from Bilthoven and 35 women from Utrecht. Ferritin, total iron, total iron-binding capacity, transferrin saturation, transferrin, C-reactive protein, bilirubin, cholesterol, triglycerides, apo lipoprotein-A, apo lipoprotein-B, high-density lipoproteins, low-density lipoproteins, uric acid, creatinine, reactive oxygen metabolites, the ferric-reducing ability of plasma, protein thiol oxidation, fructosamine, and vitamin D biomarkers in serum were analysed from the blood samples at the two points of time. For all biomarkers, except C-reactive protein, there were no substantial changes in the mean levels over time. Uric acid, ferritin, creatinine, HDL, and apo lipoprotein-B levels consistently showed the highest reliability for men and women (intra-class correlation = 0.69-0.86). Among women, the ferric-reducing ability of plasma, and protein thiol oxidation had poor reliability; and among men iron-related biomarkers (except serum ferritin) had poor reliability. With the exception of a few gender-specific differences, most of the 20 biomarkers performed well and can be considered to have sufficient reliability to be used in future cohort studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908443     DOI: 10.1080/13547500600799748

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  29 in total

1.  A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults.

Authors:  Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

2.  Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.

Authors:  Jeffrey S Berger; Aileen P McGinn; Barbara V Howard; Lewis Kuller; Joann E Manson; Jim Otvos; J David Curb; Charles B Eaton; Robert C Kaplan; John K Lynch; Daniel M Rosenbaum; Sylvia Wassertheil-Smoller
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

3.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

4.  Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies.

Authors:  Jacob Hunnicutt; Ka He; Pengcheng Xun
Journal:  J Nutr       Date:  2014-01-08       Impact factor: 4.798

5.  Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults.

Authors:  Jennifer S Sonderman; Heather M Munro; William J Blot; Lisa B Signorello
Journal:  Am J Epidemiol       Date:  2012-09-13       Impact factor: 4.897

6.  Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites.

Authors:  Jacqueline Chan; Karen Jaceldo-Siegl; Gary E Fraser
Journal:  Cancer Causes Control       Date:  2009-12-11       Impact factor: 2.506

7.  Genetic Ancestry, Skin Reflectance and Pigmentation Genotypes in Association with Serum Vitamin D Metabolite Balance.

Authors:  Robin Taylor Wilson; Alanna N Roff; P Jenny Dai; Tracey Fortugno; Jonathan Douds; Gang Chen; Gary L Grove; Sheila Ongeri Nikiforova; Jill Barnholtz-Sloan; Tony Frudakis; Vernon M Chinchilli; Terryl J Hartman; Laurence M Demers; Mark D Shriver; Victor A Canfield; Keith C Cheng
Journal:  Horm Mol Biol Clin Investig       Date:  2011-09

8.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.

Authors:  Mathilde His; Laurent Zelek; Mélanie Deschasaux; Camille Pouchieu; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Paule Latino-Martel; Jacques Blacher; Mathilde Touvier
Journal:  Eur J Epidemiol       Date:  2014-02-13       Impact factor: 8.082

9.  Association between serum 25(OH)D and death from prostate cancer.

Authors:  S Tretli; E Hernes; J P Berg; U E Hestvik; T E Robsahm
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

10.  Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.

Authors:  Mazda Jenab; H Bas Bueno-de-Mesquita; Pietro Ferrari; Franzel J B van Duijnhoven; Teresa Norat; Tobias Pischon; Eugène H J M Jansen; Nadia Slimani; Graham Byrnes; Sabina Rinaldi; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Rudolf Kaaks; Jakob Linseisen; Heiner Boeing; Manuela M Bergmann; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; Franco Berrino; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Martine M Ros; Carla H van Gils; Petra H Peeters; Magritt Brustad; Eiliv Lund; María-José Tormo; Eva Ardanaz; Laudina Rodríguez; Maria-José Sánchez; Miren Dorronsoro; Carlos A Gonzalez; Göran Hallmans; Richard Palmqvist; Andrew Roddam; Timothy J Key; Kay-Tee Khaw; Philippe Autier; Pierre Hainaut; Elio Riboli
Journal:  BMJ       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.